Management of haemophilia and its complications in developing countries

Clinical and Laboratory Haematology

Volumn 26, Issue 4, 2004, Pages 243-251

  Ghosh, K ^a  

^a KEM HOSPITAL   (India)

Author keywords

Complications; Developing countries; Haemophilia; Management; Review

Indexed keywords

AMINOCAPROIC ACID; ANALGESIC AGENT; ANTIFIBRINOLYTIC AGENT; BATROXOBIN; BLOOD CLOTTING FACTOR 8; CELECOXIB; DESMOPRESSIN; DEXTROPROPOXYPHENE; FIBRIN GLUE; HLA B27 ANTIGEN; INTERFERON; PARACETAMOL; PENICILLAMINE; PREDNISOLONE; RIBAVIRIN; RIFAMPICIN; ROFECOXIB; SCOPOLAMINE BUTYL BROMIDE; SPASMOLYTIC AGENT; THROMBIN; TRANEXAMIC ACID;

ARTHROPATHY; ASPIRATION; BLEEDING; BRAIN HEMORRHAGE; CERVICAL SPINE; CLINICAL FEATURE; CRYOPRECIPITATE; DEVELOPING COUNTRY; DISEASE PREDISPOSITION; DRUG COST; EPISTAXIS; EXCHANGE BLOOD TRANSFUSION; FASCIOTOMY; FEMORAL NERVE; GAS GANGRENE; GOVERNMENT; HEALTH CARE FACILITIES AND SERVICES; HEALTH CARE FACILITY; HEALTH CARE PLANNING; HEMARTHROSIS; HEMOPHILIA; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDRATION; IMMUNOMODULATION; MANAGEMENT; MEDICAL EDUCATION; MUSCLE TRANSPLANTATION; NERVE PARALYSIS; ORGANIZATION; ORTHOTICS; PAIN; PATIENT; PATIENT EDUCATION; PHYSICIAN; PHYSIOTHERAPY; PRENATAL DIAGNOSIS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSTHESIS; PSEUDOCYST; RARE DISEASE; REVIEW; SCIATIC NERVE; SPINAL CORD HEMORRHAGE; SPLEEN RUPTURE; SYNOVIORTHESIS; SYNOVITIS; TAI CHI; TENDON TRANSFER; TENOTOMY; UROLITHIASIS; VIRUS HEPATITIS; VIRUS INFECTION; VOLKMANN CONTRACTURE;

DEVELOPING COUNTRIES; DISEASE MANAGEMENT; HEMOPHILIA A; HUMANS; INTERNATIONAL AGENCIES;

EID: 4043131699     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2257.2004.00590.x     Document Type: Review

References (63)

1. Adewuy J.O., Coutts A.M., Levy L. & Loyodo S.E. (1996) Haemophilia care in Zimbabwe. Central African Journal of Medicine 42, 153-156.
2. Aledort L.M. & Dimichele D.M. (1998) Inhibitors occur more frequently in African American and Latino haemophiliacs. Haemophilia 4, 68-69.
3. Aledort L.M. & Levine P.H. (1977) Surgery in Haemophilia. The National Haemophilia Foundation, USA, 1-8.
4. Battistella L.R. (1998) Rehabilitation in haemophilia - options in the developing world. Haemophilia 4, 486-490.
5. Berntrop E., Boulyjenkov V., Breiter D., Chandy M., Jones P., Lee C., Lusher J., Mannucci P., Peak I. et al. (1995) Modern treatment of haemophilia. Bulletin of the World Health Organization 73, 691-701.
6. Bhave A., Srivastava A., Lee V., Daniel A.J., Dennison D., Sunderraj G.D. & Sundersanam A. (1995) Low dose activated factor IX complex concentrate (FEIBA) for post-operative haemostasis in a patient with high responding factor VIII inhibitor. Haemophilia 1, 274-276.
7. Brown S.A., Aledrot L.M. and the Round Table Group (1998) Unsolved problems in haemophilia. Haemophilia 4, 341-345.
8. Chandy M. (1995) Management of haemophilia in developing countries with availablle resources. Haemophilia 1, 44-48.
9. Cleary P.D. (2003) A hospitalisation from hall: a patients perspective on quality. Annals of International Medicine 138, 33-39.
10. Corrigan J.J. Jr., Damiano M.L., Leissinger C. & Wulf K. (2003) Treatment of chronic haemophilic synovitis in humans with d- penicielamine. Haemophilia 9, 64-68.
11. Danusantoso H. & Heijnen L. (2001) "Tai chi chuan" for people with haemophilia. Haemophilia 7, 437-440.
12. Dietrich S.L. (1996) The treatment of haemophilia bleeding problem with limited or no use of replacement therapy. WFH Bulletin 1. World Federation of Haemophilia, Montreal, Geneva.
13. Dusheiko G.M. (1998) Therapy for chronic hepatitis B and C infection in haemophilia. Haemophilia 4, 577-586.
14. Ehl S., Severin T. & Sutor A.H. (2000) DDAVP (desmopressin, 1 deaminocys-8D arginine-vasopression) treatment in children with haemophilia B. British Journal of Haematology 111, 1260-1262.
15. Evatt B.L. (2002) Observations from global survey 2001 - an emerging database for progress. Haemophilia 8, 153-156.
16. Feng J., Drost J.B., Scaringe W.A., Lin Q. & Sommers S.S. (2002) Mutations in factor IX gene during past 150 years have relative rates similar to ancient mutations. Human Mutation 19, 49-57.
17. Fernasndez-Palazzi F. (1998) Treatment of acute and chronic synovitis by non surgical means. Haemophilia 4, 518-523.
18. Fischer K., Astermark A, Van Der Born J.G., LJung R., Berntrop E., Grobee D.E. & Van Den Berg H.M. (2002) Prophylactic treatment for haemophilia: comparision of an intermediate and high dose regimen. Haemophilia 8, 753-760.
19. Ghosh K., Jijina F., Pathare A.V. & Mohanty D. (1998) Surgery in haemophilia: experience from a centre in India. Haemophilia 4, 94-97.
20. Ghosh K., Jijina F., Pathare A.V. & Mohanty D. (1999) Gas gangrene in a patient with severe haemophilia A. Haemophilia 5, 301-305.
21. Ghosh K., Joshi S.H., Shetty S., Pawar A., Chipkar S., Pujari V., Madkaikar M., Pathare A.V., Jijina F. & Mohanty D. (2000a) Transfusion transmitted diseases in haemophilia from western India. Indian Journal of Medical Research 112, 61-64.
22. Ghosh K., Shetty S., Pathare A. & Mohanty D. (2000b) Epsilon Amino caproic acid inhibits the activity of factor VIII inhibitors in patients with severe haemophilia A in vivo and vitro. Acta Haematologica 103, 67-72.
23. Ghosh K., Shetty S., Kulkarni B., Nair S., Pawar A., Khare A., Baindur S. & Mohanty D. (2001a) Development of inhibitors in patients with haemophilia from India. Haemophilia 7, 273-278.
24. Ghosh K., Shetty S. & Mohanty D (2001b) Haemorrhage in the upper cervical cord; an unusual manifestation in moderate haemophilia patients who ride motor bikes. Haemophilia 7, 515-518.
25. Ghosh K., Jijina F., Shetty S., Madkaikar M. & Mohanty D. (2002a) First time development of factor VIII inhibitors in haemophilia patients during postoperative period. Haemophilia 8, 776-780.
26. Ghosh K., Shetty S., Pawar A. & Mohanty D. (2002b) Carrier detection and prenatal diagnosis in haemophilia in India. Realities and challenges. Haemophilia 8, 51-55.
27. Ghosh K., Madkaiker M., Jijina F., Gandhi S., Shetty S. & Mohanty D. (2003a) Open heart surgery with mitral valve replacement - Ordeal of an undiagnosed haemophilia patient. Clinical and Laboratory Haematology 25, 131-133.
28. Ghosh K., Shankarkumar U., Shetty S. & Mohanty D. (2003b) Chronic synovitis and HLA - B27 in patients with severe haemophilia. Lancet 361, 933-934.
29. Ghosh K., Jijina F. & Mohanty D. (2003c) Haematuria and urolithiasis in patients with haemophilia. European Journal of Haematology 70, 410-412.
30. Giangrande P.L.F., Mariani G. & Black C. (2003) The WFH haemophilia center twinning programme: 10 years of growth, 1993-2003. Haemophilia 9, 242-244.
31. Gupta S., Mahapatra B.B., Ghai S., Seith A., Kashyap R., Sharma R. & Choudhry V.P. (2001) Haemophilic pseudotumour of the paranasalinuses: management with radiotherapy and factor replacement therapy. Haemophilia 7, 595-599.
32. Haemophilia of Georgia USA. (2000) Protocols for treatment of haemophilia and Von Willebrand disease. Haemophilia 6, 84-93.
33. Heijnen L. (Ed.) (1995) Recent Advances in Rehabilitation in Haemophilia. Medical Education Network, Sussex.
34. Heijnen L., Heim M., In Der Maur H. (2000). Manufactured shoes (shoes) and orthopaedic shoes. Haemophilia 6, 4-6.
35. Kale J. (1999) Guide to Exercises for Haemophiliacs, Haemophilia Society Mumbai (Chapter). Bhalani Publishing House, Mumbai.
36. Kale J.S., Ghosh K., Mohanty D., Pathare A.V. & Jijina F. (2000) Use of dual force system to correct chrome knee deformities due to severe haemophilia. Haemophilia 6, 177-180.
37. Kasper C.K., Boylen A.L., Ewing N.P., Luck J.V., Dietrich S.L. (1985) Haematologic Management of haemophilia A for surgery. Journal of the American Medical Association 253, 1279-1283.
38. Kavakli K., Nishi G. (2001) Cicumcision, hemophilia and being healthy In developing countries. Pediatric Hematology and Oncology 18, 419-420.
39. Kitchens C.S. (1986) Surgery in haemophilia and related disorders: a prospective study of 100 consecutive procedures. Medicine (Baltimore) 65, 35-45.
40. Lee C.A. (1998) World Federation of Haemophilia developing world programme. Haemophilia 4, 59-63.
41. Magallon M., Monteagudo J., Altisent C., Ibanez A., Roddriques-Perez A., Riba J., Tussell J. & Martin Villar J. (1994) Hemophilic pseudotumour: multicenter experience over a 25 year period. American Journal of Hematology 45, 103-108.
42. Mannuci P.M. (2000) Desmopression (DDAVP) in the treatment of bleeding disorders the first twenty years. Haemophilia 6, 60-67.
43. Markis M., Berglin T., Dusheiko G., Giangrande P.L.F., Lee C.A., Ludlam C., Preston P.E., Watson H.G., Wilde J.T. & Winter M. (2001) Guide lines on diagnosis, management and prevention of hepatitis in haemophilia. Haemophilia 7, 339-345.
44. Martinowitz U., Schuklmann S., Gitel S., Horozowskitt, Heim K. & Vason D. (1992). Adjustment dose continuous infusion of factor VIII in patients with haemophilia. British Journal of Haematology 82, 729-734.
45. Mc Millan N., Belch J.J., Rolfe E.B., Forbes C.D. & Stuart J. (1982) Haemophilia and the kidney: assessment after 11 years of follow up. British Medical Journal 285, 1609-1611.
46. Meyer L. & Hakami N. (1985) Pseudotumour of haemophilia in the orbit: the role of radiotherapy in the management. American Journal of Haematology 19, 99-102.
47. Oldenberg J., Picard J.K., Schwab R., Brackmann H.H., Tuddenham E.G.D. & Simpson E. (1997) HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors to factor VIII. Thrombosis and Haemostasis 77, 238-242.
48. Ribbans W.J., Giangrande P. & Beton K. (1997) Conservative treatment of haemarthrosis for prevention of haemophiliac synovitis. Clinical Orthopedics 343, 12-18.
49. Rizza C.R. (1980) Inhibitor of fibrinolysis in the treatment of haemophilia. Journal of Clinical Pathology 14, 50-54.
50. Rizza C.R., Spooner R.J.D. & Giangrande P.L.F. (2001) Treatment of haemophilia in the United Kingdom: 1981-1996. Haemophilia 7, 349-359.
51. Rodriguez Merchan E.C. (2001) Methods to treat chronic haemophiliac synovitis. Haemophilia 7, 1-5.
52. Samaiya A., Gupta S., Chumber S., Kashyap R., Dewanda N.K., Vashist S. & Choudhary V.P. (2001) Blunt abdominal trauma with delayed rupture of splenic haematoma in a haemophiliac patient. Haemophilia 7, 331-334.
53. Saraf S.K., Singh O.P. & Singh V.P. (2003) Peripheral nerve complications in haemophilia. JAPI 51, 167-169.
54. Shetty S., Ghosh K., Anbhavne S. & Mohanty D. (2003) Requiem to prenatal diagnosis of haemophilia A & B using coagulation activity and antigen based assays: not yet! European Journal of Haematology 70, 253-254.
55. Shittu O.B. & Shokunbi W.A. (2001) Circimcision in haemophiliacs: the Nigerian experience. Haemophilia 7, 532-536.
56. Silva M., Luck J.V. Jr & Siegal M.E. (2001) 32p Chromic phosphate radio synovectomy for chronic haemophilic synovitis. Haemophilia 7, 40-49.
57. Srivastava A., Chuan Sumrit A., Chandy M., Duraiswamy G. & Karabus C. (1998a) Management of haemophilia in the developing world. Haemophilia 4, 474-480.
58. Srivastava A., Chandy M., Sunderrajan G.D., Lee V., Daniel A.J., Dennison D., Nair S.C., Mathews V., Anderson G., Nair A., Moses B.V. & Sundersanam A. (1998b) Low dose intermittent factor replacement for post operative haemostasis in haemophilia. Haemophilia 4, 799-801.
59. Tizzano E.F., Altisent C., Domenech M., Cornet Tussel J. & Baiger M. (1996) Inhibitor development in haemophilia A patients with inversion of intron 22 of the factor VIH gene. Thrombosis and Haemostasis 76, 125-126.
60. Varon D. & Martinowitz U. (1998) Continuous infusion therapy in haemophilia. Haemophilia 4, 431-435.
61. Vermylen J. (1998) How do some haemophiliacs develop inhibitors? Haemophilia 4, 538-542.
62. Wallny T., Saker A., Hofman P., Brackman H.H., Nicolay C. & Kraft C.N. (2003) Long term follow up after osteotomy for haemophilic arthropathy of the knee. Haemophilia 9, 69-75.
63. Yee T.T., Williams M.D., Hill F.G., Lee C.A. & Pasik J. (1997) Absence of inhibitors in previously untreated patients with severe haemophilia A after exposure to a single intermediate purity factor VIII product. Thrombosis and Haemostasis 78, 1027-1029.